Several of those genes are known tumor suppressors that are hypermethylated in solid cancers (CACNA1G, IRF6, ITGA9, and PPP2R2C) and used as biomarkers related to adverse outcome [38–51]. This evidence concerns the gene PPP2R2C and neoplasm.